[Giant cell arteritis. Experience in 32 patients]

Pamela Wurmann1, Claudia Hernández1, Pedro Zamorano1

  • 1Hospital Clínico, Universidad de Chile, Santiago, Chile.

Revista Medica De Chile
|October 31, 2023
PubMed

Insights

Giant cell arteritis (GCA) diagnosis in patients over 50 often involves extracranial disease, and temporal artery biopsy (TAB) is a useful diagnostic tool. Many patients achieve remission with steroids and steroid-sparing agents like methotrexate.

Area of Science:

  • Rheumatology
  • Vasculitis Research
  • Systemic Autoimmune Diseases

Context:

  • Giant cell arteritis (GCA) is the most common systemic vasculitis affecting individuals over 50.
  • Diagnosis relies on clinical, laboratory, imaging, and biopsy findings.
  • Temporal artery biopsy (TAB) can be inconclusive in up to 40% of cases.

Purpose:

  • To characterize the disease manifestations in patients diagnosed with GCA.
  • To evaluate the utility of diagnostic tools, including TAB, in GCA management.

Summary:

  • This study reviewed 32 patients diagnosed with GCA between 2000 and 2019, with a median age of 70.5 years (81% female).
  • Frequent extracranial involvement (25%) was observed, alongside cranial symptoms (72%).
  • Temporal artery biopsy confirmed the diagnosis in 65.4% of cases, with transmural inflammation being the most common finding. All patients received steroids, and 92% achieved remission within the first year, often with steroid-sparing agents like methotrexate.

Impact:

  • Highlights the significant prevalence of extracranial involvement in GCA, underscoring the need for comprehensive diagnostic approaches.
  • Reinforces the value of temporal artery biopsy as a key diagnostic modality in suspected GCA cases.
  • Demonstrates the effectiveness of current treatment strategies, including steroids and steroid-sparing agents, in achieving clinical remission for GCA patients.
Abstract